Schedule 13D ownership disclosure
Acumen Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 00509G209
Event date: 2021-09-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,774,551
- Percent of class
- 24.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-115109
- Form type
- SC 13D
- Filer
- Acumen Pharmaceuticals, Inc.
- CIK
- CIK 1576885
- Filed
- Sep 13, 2021
- Reporting period
- Sep 10, 2021
- Description
- Schedule 13D beneficial ownership